White Paper: Must-Know Finance Concepts for Life Sciences Valuations

05.28.2016

This white paper, based on the webinar by the same name, presents an introduction to the key concepts and most common methodologies used to evaluate life sciences assets.

If you are an entrepreneur who is, or will be, raising financing, licensing an asset or selling your company, a private investor who wants to estimate and negotiate start-up share value, or any other professional who is active in the investing sector, you’ll benefit from this overview of the key concepts used in life sciences valuation discussions.

Topics covered include:

The various valuation methodologies used to assign a value to life science businesses and assets

The methodologies used in particular by pharma partners and venture capitalists

An explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital and present value

Request the white paper on the ShareVault website.

Based on a webinar presented by John Selig and Jeff Karan, Co-Founders and Managing Partners at WaveEdge Capital.